Two Faces of Neutrophils in Liver Disease Development and Progression. Publication: Journal Article Cho, Yeonhee, and Gyongyi Szabo. 2021. “Two Faces of Neutrophils in Liver Disease Development and Progression.”. Hepatology (Baltimore, Md.) 74 (1): 503-12.
Exosomes and MicroRNA-223 at the Intersection of Inflammation and Fibrosis in NAFLD. Publication: Journal Article Szabo, Gyongyi. 2021. “Exosomes and MicroRNA-223 at the Intersection of Inflammation and Fibrosis in NAFLD.”. Hepatology (Baltimore, Md.) 74 (1): 5-8.
Lipoprotein Z, a hepatotoxic lipoprotein, predicts outcome in alcohol-associated hepatitis. Publication: Journal Article Hu, Kunpeng, Maria C Perez-Matos, Josepmaria Argemi, Eduardo Vilar-Gomez, Irina Shalaurova, Esther Bullitt, Lee Landeen, et al. 2022. “Lipoprotein Z, a Hepatotoxic Lipoprotein, Predicts Outcome in Alcohol-Associated Hepatitis.”. Hepatology (Baltimore, Md.) 75 (4): 968-82.
Transcriptional regulation of Acsl1 by CHREBP and NF-kappa B in macrophages during hyperglycemia and inflammation. Publication: Journal Article Thevkar-Nagesh, Prashanth, Justine Habault, Maud Voisin, Sophie E Ruff, Susan Ha, Rachel Ruoff, Xi Chen, et al. 2022. “Transcriptional Regulation of Acsl1 by CHREBP and NF-Kappa B in Macrophages During Hyperglycemia and Inflammation.”. PloS One 17 (9): e0272986.
Innate immune activation: Parallels in alcohol use disorder and Alzheimer's disease. Publication: Journal Article Ramos, Adriana, Radhika S Joshi, and Gyongyi Szabo. 2022. “Innate Immune Activation: Parallels in Alcohol Use Disorder and Alzheimer’s Disease.”. Frontiers in Molecular Neuroscience 15: 910298.
IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis. Publication: Journal Article Szabo, Gyongyi, Mack Mitchell, Craig J McClain, Srinivasan Dasarathy, Bruce Barton, Arthur J McCullough, Laura E Nagy, et al. 2022. “IL-1 Receptor Antagonist Plus Pentoxifylline and Zinc for Severe Alcohol-Associated Hepatitis.”. Hepatology (Baltimore, Md.) 76 (4): 1058-68.
Differential role of MLKL in alcohol-associated and non-alcohol-associated fatty liver diseases in mice and humans. Publication: Journal Article Miyata, Tatsunori, Xiaoqin Wu, Xiude Fan, Emily Huang, Carlos Sanz-Garcia, Christina K Cajigas-Du Ross, Sanjoy Roychowdhury, et al. 2022. “Differential Role of MLKL in Alcohol-Associated and Non-Alcohol-Associated Fatty Liver Diseases in Mice and Humans.”. JCI Insight 7 (23).
G-CSF increases calprotectin expression, liver damage and neuroinflammation in a murine model of alcohol-induced ACLF. Publication: Journal Article Ortega-Ribera, Martí, Yuan Zhuang, Veronika Brezani, Prashanth Thevkar Nagesh, Radhika S Joshi, Mrigya Babuta, Yanbo Wang, and Gyongyi Szabo. 2024. “G-CSF Increases Calprotectin Expression, Liver Damage and Neuroinflammation in a Murine Model of Alcohol-Induced ACLF.”. Frontiers in Cell and Developmental Biology 12: 1347395.
Neutrophil extracellular traps activate hepatic stellate cells and monocytes via NLRP3 sensing in alcohol-induced acceleration of MASH fibrosis. Publication: Journal Article Babuta, Mrigya, Caroline Morel, Marcelle de Carvalho Ribeiro, Charles Calenda, Martí Ortega-Ribera, Prashanth Thevkar Nagesh, Christopher Copeland, et al. 2024. “Neutrophil Extracellular Traps Activate Hepatic Stellate Cells and Monocytes via NLRP3 Sensing in Alcohol-Induced Acceleration of MASH Fibrosis.”. Gut.
Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation. Publication: Journal Article Taru, Vlad, Gyongyi Szabo, Wajahat Mehal, and Thomas Reiberger. 2024. “Inflammasomes in Chronic Liver Disease: Hepatic Injury, Fibrosis Progression and Systemic Inflammation.”. Journal of Hepatology.